MAPK8 and Parkinson disease: Furthermore, JNK inhibition by SP-600125 or SR-3306 inhibitors mitigates dopaminergic neuronal apoptosis in MPTP and/or 6-OHDA PD models in vivo and MPP+-induced neurotoxic PD models in vitro [64,65].